# Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-treatment-with-trastuzumab-in-her2-positive-breast-cancer-results/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael Untch,Mahdi Rezai,Sibylle Loibl,Peter A. Fasching,Jens Huober,Hans Tesch,Ingo Bauerfeind,J. Hilfrich,Holger Eidtmann,Bernd Gerber,Claus Hanusch,Thorsten Kühn,Andreas du Bois,Jens‐Uwe Blohmer,Christoph Thomssen,Serban Dan Costa,Christian Jackisch,Manfred Kaufmann,Keyur Mehta,Gϋnter von Minckwitz |
| Citations | 557 |
| DOI | 10.1200/jco.2009.23.8451 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.23.8451 |
| OpenAlex ID | https://openalex.org/W2117984780 |
| PMID | 20308670 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Jens‐Uwe Blohmer](https://scholariq.org/researchers/jens-uwe-blohmer/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.